Intranasal naloxone delivery is an alternative to intravenous naloxone for opioid overdoses

American Journal of Emergency Medicine

Volumn 28, Issue 3, 2010, Pages 296-303

  Merlin, Mark A ^a,b   Saybolt, Matthew ^c   Kapitanyan, Raffi ^a   Alter, Scott M ^c   Jeges, Janos ^a   Liu, Junfeng ^a,d   Calabrese, Susan ^b   Rynn, Kevin O ^b,e   Perritt, Rachael ^b,e   Pryor II, Peter W ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^e RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NALOXONE;

ADULT; AGED; ARTICLE; BREATHING RATE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG OVERDOSE; FEMALE; GLASGOW COMA SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENTAL HEALTH; OPIOID OVERDOSE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADMINISTRATION, INTRANASAL; ADULT; AGED; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; NALOXONE; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; OVERDOSE; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 77649215413     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2008.12.009     Document Type: Article

References (24)

1. Marcus R., Srivastava P.U., Bell D.M., et al. Occupational blood contact among prehospital providers. Ann Emerg Med 25 (1995) 776-779
2. Shelly K., and Paech M.J. The clinical applications of intranasal opioids. Curr Drug Deliv. 5 (2008) 55-58
3. Hollander M., and Wolfe D.A. Nonparametric statistical methods. 2nd ed. (1999), John Wiley and Sons Inc., New York 89-109
4. Glass P.S., Jhaveri R.M., and Smith L.R. Comparison of potency and duration of action of nalmefene and naloxone. Anesth Analg 78 (1994) 536-541
5. Albeck H., Woodfield S., and Kreek M.J. Quantitative and pharmacokinetic analysis of naloxone in plasma using high-performance liquid chromatography with electrochemical detection and solid-phase extraction. J Chromatogr 488 (1989) 435-445
6. Ngai S.H., Berkowitz B.A., Yang J.C., et al. Pharmacokinetics of naloxone in rats and in man: basis for its potency and short duration of action. Anesthesiology 44 (1976) 398-401
7. Evans J.M., Hogg M.J., Lunn J.N., et al. Degree and duration of reversal by naloxone of effects of morphine in conscious subjects. Br Med J 2 (1974) 589-591
8. Behl C.R., Pimplaskar H.K., Sileno A.P., et al. Effects of physiochemical properties and other factors on systemic nasal delivery. Adv Drug Deliv Rev 29 (1998) 89-116
9. Dominique D., and Gilles P. Nasal Administration: A Tool for Tomorrow's Systemic Administration of Drugs. Drug Dev Ind Pharm 19 (1993) 101-122
10. Hussain A., Kimura R., Huang C.H., et al. Nasal absorption of naloxone and buprenorphine in rats. Int J Pharm 21 (1984) 233-237
11. Barton E.D., Colwell C.B., Wolfe T., et al. Efficacy of intranasal naloxone as a needless alternative for treatment of opioid overdose in the prehospital setting. J Emerg Med 29 (2005) 265-271
12. Kelly A.M., Kerr D., Dietze P., et al. Randomized trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose. Med J Aust 182 (2005) 24-27
13. Loimer N., Hofmann P., and Chaudhry H.R. Nasal administration of naloxone is as effective as the intravenous route in opiate addicts. Int J Addict 29 (1994) 819-827
14. Ashton H., and Hassan Z. Intranasal naloxone in suspected opioid overdose. Emerg Med J 23 (2006) 221-223
15. Kelly A.M., and Koutsogiannis Z. Intranasal naloxone for life threatening opioid overdose. Emerg Med J 19 (2002) 375
16. Barton E.D., Ramos J., Colwell C., et al. Intranasal administration of naloxone by paramedics. Prehosp Emerg Care 6 (2002) 542-548
17. Robertson T.M., Hendey G.W., Stroh G., et al. Intranasal versus intravenous naloxone for prehospital narcotic overdose. Acad Emerg Med 12 Suppl 1 (2005) 166-167
18. Hodges Jr. J.L., and Lehmann E.L. Hodges-Lehmann estimators. In: Kotz S., Johnson N.L., and Read C.B. (Eds). Encyclopedia of Statistical Sciences Vol. 3 (1983), John Wiley, New York 463-465
19. Noether G.E. Sample size determination for some common nonparametric tests. Journal of American Statistical Association 82 (1987) 645-647
20. Nelson L.S. In: Goldfrank L.R., Flomenbaum N.E., Lewin N.A., et al. (Eds). Opioids in Goldfrank's toxicologic emergencies. 7th ed. (2002), McGraw-Hill, New York 901-923
21. Marttin E., Schipper N.G.M., Verhoef J.C., et al. Nasal mucociliary clearance as a factor in nasal drug delivery. Adv Drug Deliv Rev 29 (1998) 13-38
22. Fulton J.A., Greller H.A., and Hoffman R.S. GCS and AVPU: the alphabet soup doesn't spell "C-O-M-A" in toxicology. Ann Emerg Med 45 (2005) 224-225
23. Walther S.M., Jonasson U., and Gill H. Comparison of the Glasgow Coma Scale and the Reaction Level Scale for assessment of cerebral responsiveness in the critically ill. Intensive Care Med 29 (2003) 933-938
24. Weir C.J., Bradford A.P., and Lees K.R. The prognostic value of the components of the Glasgow Coma Scale following acute stroke. QJM. 96 (2003) 67-74